Wuhan Keqian Biology Co Ltd Cash Flow-to-Debt Ratio
Wuhan Keqian Biology Co Ltd cash flow-to-debt ratio. Wuhan Keqian Biology Co Ltd (688526) has a Cash Flow-to-Debt Ratio of 0.30x as of September 2025, meaning its operating cash flow of CN¥174.36 Million could theoretically repay 0% of its total liabilities (CN¥580.21 Million) in one year. Check 688526 cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Wuhan Keqian Biology Co Ltd (2016–2024)
Cash flow-to-debt ratio of Wuhan Keqian Biology Co Ltd from 2016 to 2024. Historical debt coverage capacity for Wuhan Keqian Biology Co Ltd across 9 annual periods. Check how aggressively does Wuhan Keqian Biology Co Ltd reinvest cash to assess the company's total reinvestment commitment from operating cash flow.
Wuhan Keqian Biology Co Ltd Cash Flow-to-Debt Ratio by Year (2016–2024)
Wuhan Keqian Biology Co Ltd cash flow-to-debt ratio by year from 2016 to 2024. Year-by-year debt coverage analysis for Wuhan Keqian Biology Co Ltd. For the full cash flow conversion analysis, see 688526 operating cash flow.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 0.71x | CN¥392.68 Million | CN¥552.80 Million | ▲ +10.1% |
| 2023 | 0.65x | CN¥538.03 Million | CN¥833.59 Million | ▲ +35.8% |
| 2022 | 0.48x | CN¥423.71 Million | CN¥891.63 Million | ▼ -48.9% |
| 2021 | 0.93x | CN¥531.27 Million | CN¥571.41 Million | ▼ -6.5% |
| 2020 | 0.99x | CN¥400.14 Million | CN¥402.40 Million | ▲ +62.1% |
| 2019 | 0.61x | CN¥154.89 Million | CN¥252.48 Million | ▼ -38.4% |
| 2018 | 1.00x | CN¥351.83 Million | CN¥353.51 Million | ▼ -23.7% |
| 2017 | 1.30x | CN¥337.61 Million | CN¥258.86 Million | ▲ +5.8% |
| 2016 | 1.23x | CN¥220.69 Million | CN¥179.01 Million | — |